Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene

被引:57
作者
Paterson, Andrew D. [2 ,3 ,4 ]
Rommens, Johanna M. [2 ]
Bharaj, Bhupinder [2 ]
Blavignac, Jessica [1 ]
Wong, Isidro [2 ]
Diamandis, Maria [1 ]
Waye, John S. [1 ]
Rivard, Georges E. [5 ]
Hayward, Catherine P. M. [1 ,6 ]
机构
[1] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada
[2] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[4] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada
[5] Ctr Hosp Univ St Justine, Montreal, PQ, Canada
[6] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada
基金
加拿大健康研究院;
关键词
FACTOR-V; EXPRESSION; DIFFERENTIATION; MEGAKARYOCYTES; DEGRADATION; FIBRINOGEN; FAMILY; DEFECT;
D O I
10.1182/blood-2009-07-233965
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Quebec platelet disorder (QPD) is an autosomal dominant bleeding disorder linked to a region on chromosome 10 that includes PLAU, the urokinase plasminogen activator gene. QPD increases urokinase plasminogen activator mRNA levels, particularly during megakaryocyte differentiation, without altering expression of flanking genes. Because PLAU sequence changes were excluded as the cause of this bleeding disorder, we investigated whether the QPD mutation involved PLAU copy number variation. All 38 subjects with QPD had a direct tandem duplication of a 78-kb genomic segment that includes PLAU. This mutation was specific to QPD as it was not present in any unaffected family members (n = 114), unrelated a French Canadians (n = 221), or other persons tested (n = 90). This new information on the genetic mutation will facilitate diagnostic testing for QPD and studies of its pathogenesis and prevalence. QPD is the first bleeding disorder to be associated with a gene duplication event and a PLAU mutation. (Blood. 2010;115:1264-1266)
引用
收藏
页码:1264 / 1266
页数:3
相关论文
共 20 条
[1]   Matlnspector and beyond: promoter analysis based on transcription factor binding sites [J].
Cartharius, K ;
Frech, K ;
Grote, K ;
Klocke, B ;
Haltmeier, M ;
Klingenhoff, A ;
Frisch, M ;
Bayerlein, M ;
Werner, T .
BIOINFORMATICS, 2005, 21 (13) :2933-2942
[2]   Systematic assessment of copy number variant detection via genome-wide SNP genotyping [J].
Cooper, Gregory M. ;
Zerr, Troy ;
Kidd, Jeffrey M. ;
Eichler, Evan E. ;
Nickerson, Deborah A. .
NATURE GENETICS, 2008, 40 (10) :1199-1203
[3]   Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis [J].
Diamandis, M ;
Adam, F ;
Kahr, WHA ;
Wang, P ;
Chorneyko, KA ;
Arsenault, AL ;
Rivard, GE ;
Hayward, CPM .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (05) :1086-1094
[4]   Quebec platelet disorder: features, pathogenesis and treatment [J].
Diamandis, Maria ;
Veljkovic, D. Kika ;
Maurer-Spurej, Elisabeth ;
Rivard, Georges E. ;
Hayward, Catherine P. M. .
BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (02) :109-119
[5]   Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes [J].
Diamandis, Maria ;
Paterson, Andrew D. ;
Rommens, Johanna M. ;
Veljkovic, D. Kika ;
Blavignac, Jessica ;
Bulman, Dennis E. ;
Waye, John S. ;
Derome, Francine ;
Rivard, Georges E. ;
Hayward, Catherine P. M. .
BLOOD, 2009, 113 (07) :1543-1546
[6]   Evaluation of urokinase plasminogen activator in urine from individuals with Quebec platelet disorder [J].
Diarnandis, Maria ;
Veljkovic, D. Kika ;
Derome, Francine ;
Rivard, Georges E. ;
Hayward, Catherine P. M. .
BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (05) :463-464
[7]   The International HapMap Project [J].
Gibbs, RA ;
Belmont, JW ;
Hardenbol, P ;
Willis, TD ;
Yu, FL ;
Yang, HM ;
Ch'ang, LY ;
Huang, W ;
Liu, B ;
Shen, Y ;
Tam, PKH ;
Tsui, LC ;
Waye, MMY ;
Wong, JTF ;
Zeng, CQ ;
Zhang, QR ;
Chee, MS ;
Galver, LM ;
Kruglyak, S ;
Murray, SS ;
Oliphant, AR ;
Montpetit, A ;
Hudson, TJ ;
Chagnon, F ;
Ferretti, V ;
Leboeuf, M ;
Phillips, MS ;
Verner, A ;
Kwok, PY ;
Duan, SH ;
Lind, DL ;
Miller, RD ;
Rice, JP ;
Saccone, NL ;
Taillon-Miller, P ;
Xiao, M ;
Nakamura, Y ;
Sekine, A ;
Sorimachi, K ;
Tanaka, T ;
Tanaka, Y ;
Tsunoda, T ;
Yoshino, E ;
Bentley, DR ;
Deloukas, P ;
Hunt, S ;
Powell, D ;
Altshuler, D ;
Gabriel, SB ;
Qiu, RZ .
NATURE, 2003, 426 (6968) :789-796
[8]   Fibrinogen degradation products in patients with the Quebec platelet disorder [J].
Hayward, CPM ;
Welch, B ;
Bouchard, M ;
Zheng, S ;
Rivard, GE .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (02) :497-503
[9]  
Hayward CPM, 1997, BLOOD, V89, P1243, DOI 10.1182/blood.V89.4.1243
[10]   An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect [J].
Hayward, CPM ;
Rivard, GE ;
Kane, WH ;
Drouin, J ;
Zheng, SL ;
Moore, JC ;
Kelton, JG .
BLOOD, 1996, 87 (12) :4967-4978